Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

Yue Zhi Lee; Hsing Yu Hsu; Cheng Wei Yang; Yi Ling Lin; Sui Yuan Chang; Ruey Bing Yang; Jian Jong Liang; Tai Ling Chao; Chun Che Liao; Han Chieh Kao; Jang Yang Chang; Huey Kang Sytwu; Chiung Tong Chen; Shiow Ju Lee

doi:10.3390/pharmaceutics15020342

Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

Yue Zhi Lee, Hsing Yu Hsu, Cheng Wei Yang, Yi Ling Lin, Sui Yuan Chang, Ruey Bing Yang, Jian Jong Liang, Tai Ling Chao, Chun Che Liao, Han Chieh Kao, Jang Yang Chang, Huey Kang Sytwu, Chiung Tong Chen, Shiow Ju Lee

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

原文	英語
文章編號	342
期刊	Pharmaceutics
卷	15
發行號	2
DOIs	https://doi.org/10.3390/pharmaceutics15020342
出版狀態	已發佈 - 2月 2023
對外發佈	是

ASJC Scopus subject areas

藥學科學

存取文件

10.3390/pharmaceutics15020342

其它文件與鏈接

引用此

Lee, Y. Z., Hsu, H. Y., Yang, C. W., Lin, Y. L., Chang, S. Y., Yang, R. B., Liang, J. J., Chao, T. L., Liao, C. C., Kao, H. C., Chang, J. Y., Sytwu, H. K., Chen, C. T., & Lee, S. J. (2023). Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511). Pharmaceutics, 15(2), 文章 342. https://doi.org/10.3390/pharmaceutics15020342

Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511). / Lee, Yue Zhi; Hsu, Hsing Yu; Yang, Cheng Wei 等.
於: Pharmaceutics, 卷 15, 編號 2, 342, 02.2023.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Lee, YZ, Hsu, HY, Yang, CW, Lin, YL, Chang, SY, Yang, RB, Liang, JJ, Chao, TL, Liao, CC, Kao, HC, Chang, JY, Sytwu, HK, Chen, CT & Lee, SJ 2023, 'Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)', Pharmaceutics, 卷 15, 編號 2, 342. https://doi.org/10.3390/pharmaceutics15020342

@article{9e04cd2204724824afaa1302c6e0b50c,

title = "Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)",

abstract = "Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.",

author = "Lee, {Yue Zhi} and Hsu, {Hsing Yu} and Yang, {Cheng Wei} and Lin, {Yi Ling} and Chang, {Sui Yuan} and Yang, {Ruey Bing} and Liang, {Jian Jong} and Chao, {Tai Ling} and Liao, {Chun Che} and Kao, {Han Chieh} and Chang, {Jang Yang} and Sytwu, {Huey Kang} and Chen, {Chiung Tong} and Lee, {Shiow Ju}",

note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = feb,

doi = "10.3390/pharmaceutics15020342",

language = "English",

volume = "15",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "2",

}

TY - JOUR

T1 - Correction

T2 - The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

AU - Lee, Yue Zhi

AU - Hsu, Hsing Yu

AU - Yang, Cheng Wei

AU - Lin, Yi Ling

AU - Chang, Sui Yuan

AU - Yang, Ruey Bing

AU - Liang, Jian Jong

AU - Chao, Tai Ling

AU - Liao, Chun Che

AU - Kao, Han Chieh

AU - Chang, Jang Yang

AU - Sytwu, Huey Kang

AU - Chen, Chiung Tong

AU - Lee, Shiow Ju

PY - 2023/2

Y1 - 2023/2

N2 - Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

AB - Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

UR - http://www.scopus.com/inward/record.url?scp=85149407657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149407657&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics15020342

DO - 10.3390/pharmaceutics15020342

M3 - Comment/debate

AN - SCOPUS:85149407657

SN - 1999-4923

VL - 15

JO - Pharmaceutics

JF - Pharmaceutics

IS - 2

M1 - 342

ER -

Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

摘要

ASJC Scopus subject areas

存取文件

其它文件與鏈接

指紋

引用此